non-bed-rest
Behavioralfor patients with low-flow cerebrospinal fluid leak (dural defect ≤1 cm²) non-bed-rest postoperatively
NCT Number: NCT07465861
This study is a randomized controlled trial conducted across multiple centers. Due to the anatomical and pathological complexity of endoscopic endonasal skull base surgery, the study scope was restricted to the midline anterior skull base region to maximize homogeneity among enrolled cases.
After screening according to inclusion and exclusion criteria and obtaining informed consent, patients were intraoperatively classified into low-flow cerebrospinal fluid (CSF) leak (dural defect ≤1 cm²) or high-flow CSF leak (dural defect >1 cm²) groups. Patients in the low-flow group were randomly assigned to either a non-bed-rest group or a 2-day bed-rest group, while those in the high-flow group were randomly assigned to either a 1-day or a 3-day bed-rest group.
The primary outcome was the reconstruction success rate (from immediately postoperative to 1 month) compared between different bed-rest durations within the low-flow and high-flow subgroups, respectively. Secondary outcomes included the incidence of bed-rest-related postoperative adverse events during hospitalization (safety indicator), postoperative quality-of-life scores (functional indicator), length of postoperative hospital stay (days), and total treatment cost (healthcare resource utilization indicator).
By comparing these outcomes across groups, the study aims to evaluate the impact of bed-rest duration on the outcomes of endoscopic endonasal reconstruction of the midline anterior skull base, thereby providing high-quality clinical evidence to facilitate accelerated postoperative recovery.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
for patients with low-flow cerebrospinal fluid leak (dural defect ≤1 cm²) non-bed-rest postoperatively
for patients with low-flow cerebrospinal fluid leak (dural defect ≤1 cm²) 2-day bed-rest postoperatively
for patients with high-flow CSF leak (dural defect >1 cm²) 1-day bed-rest postoperatively
for patients with high-flow CSF leak (dural defect >1 cm²) 3-day bed-rest postoperatively
Time frame: within 1 month postoperatively
Time frame: low-flow group: postoperative day 2; high-flow group: postoperative day 4.
quality-of-life score is measured by Postoperative Recovery Scale for Adult (total score: 0-1000; higher is better)
Time frame: from postoperative day 1 to 14
Time frame: from postoperative day 1 to 14
Time frame: from postoperative day 1 to 14
Time frame: from postoperative day 1 to 30
stay duration in days
Time frame: from postoperative day 1 to 30
Contact information is provided by the study sponsor or research team.
Xudong Yan
CONTACT
Yan Jiang
CONTACT
The Affiliated Hospital of Qingdao University
Other
The Impact of Postoperative Bed Rest Duration on the Reconstruction Outcomes of Endoscopic Endonasal Midline Anterior Skull Base Surgery: A Multicenter Randomized Controlled Trial
Acronym: BRO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01705821
Brain Diseases, Central Nervous System Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT07539792
Cerebrospinal Fluid Leak, Cerebrospinal Fluid Rhinorrhea
Foshan, Guangdong, China
View Trial DetailsNCT05024643
Cerebrospinal Fluid Leak, Cerebrospinal Fluid Rhinorrhea
View Trial DetailsNCT03280849
Cerebrospinal Fluid Leak, Cerebrospinal Fluid Rhinorrhea
Guadalajara, Jalisco, Mexico
View Trial Details